Publications

by | November 16, 2012 | Uncategorized

Medical devices: Will the new legislation be enough to protect patients?

On 14 November, EPHA took part in an event hosted by the Alliance of Liberals and Democrats for Europe (ALDE), the third largest political group in the European Parliament (EP). The gathering brought together institutional and civil society stakeholders to discuss the efficiency of the new proposal on medical devices (including in vitro diagnostic devices).

The event brought together experts to discuss whetherthe new legislation is sufficient to guarantee patient safety. There was a wide consensus in the room to support this piece of legislation.
Sabine Lecrenier, Head of the European Commission’s Health Technologies and Cosmetics Unit, kicked off the conference by presenting the two proposals so far tabled.

Peter Liese, Rapporteur on the proposal for a regulation on in vitro diagnostics for medical devices, stressed the importance of the registration of medical devices, the rule of notified bodies, and the new system of traceability. For Mr Liese, the big issue here is whether “we need a pre-market assessment”. The question whether scrutiny procedure would be beneficial or not remains in the air.

Further concerns expressed by Mr Liese were related to data protection. With the new proposal on in vitro diagnostic medical devices, data from DNA tests, HIV tests and genomic tests will be much more accessible – warning systems will be set up to prevent details being inappropriately saved.

—-
EPHA related articles:

Get the EPHA Newsletter

The best of our activities, right in your inbox!